Indications
Prevention of poliomyelitis, alone or in combination with the oral poliomyelitis vaccine (bOPV)
PDF page 534
Loading InternPractice…
Drug reference
Prevention of poliomyelitis, alone or in combination with the oral poliomyelitis vaccine (bOPV)
PDF page 534
Vaccination should be postponed in the event of severe acute febrile illness (minor infections are not contra-indications). May cause: mild local reaction (pain, redness at the injection site), fever; exceptionally, anaphylactic reaction. Pregnancy: no contra-indication Breast-feeding: no contra-indication
PDF page 534
Inactivated virus vaccine, trivalent (poliovirus types 1, 2 and 3) Suspension for injection in multidose vial, for IM injection into the anterolateral part of the thigh in children < 2 years or deep SC injection into the deltoid muscle in children ≥ 2 years and adults
PDF page 534
bOPV + IPV schedule Child: 0.5 ml single dose at 14 weeks, in combination with a dose of bOPV IPV only schedule Child: 3 doses of 0.5 ml approximately 4 weeks apart, at 6, 10 and 14 weeks of age and a booster rd dose at least 6 months after the 3 dose
PDF page 534
Protection against poliomyelitis lasts for life after 4 doses. In children who start routine vaccination late (after the age of 3 months), the dose of IPV is st administered together with the 1 dose of bOPV, followed by 2 doses of bOPV alone administered 4 weeks apart. If there is a shortage of IPV the intradermal route is an alternative, if the operator is experienced in this administration technique. The vaccination schedule is: 2 doses of 0.1 ml at 6 and 14 weeks of age (the 2 doses must be administered at least 4 weeks apart). Certain countries have vaccination schedules for children and adults that use only the injectable vaccine and include booster doses: follow national recommendations.
PDF page 534
– Between 2 °C and 8 °C. Do not freeze.
PDF pages 534, 535
0.5 ml single dose at 14 weeks, in combination with a dose of bOPV
PDF page 534
3 doses of 0.5 ml approximately 4 weeks apart, at 6, 10 and 14 weeks of age and a booster rd dose at least 6 months after the 3 dose
PDF page 534